7 results
Initial Anticoagulation for Venous Thromboembolism (VTE)

#Anticoagulation #Initial #Initiation #Dosing #Venous #Thromboembolism #VTE #Pharmacology #Table #Management
Initial Anticoagulation ... for Venous Thromboembolism ... Initial #Initiation #Dosing ... #VTE #Pharmacology ... #Table #Management
Beta-Blockers in Cirrhosis
 • Pathophysiology
 • Indications:  Prevention of decompensation, Prevention of first variceal bleeding,
in Cirrhosis • Pathophysiology ... gastropathy • Dosing ... BetaBlockers #Cirrhosis #hepatology ... #management #pharmacology ... #indications #dosing
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
the treatment of cancer-associated ... for appropriate dosing ... mass index; VTE = venous ... #Algorithm #Anticoagulation ... #Management #Hematology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
Over-anticoagulation ... #management #algorithm ... #pharmacology # ... decisionaid #cardiology #hematology ... #warfarin #dosing
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
incidental DVT or PE in cancer ... thrombosis in cancer ... bleeding risk during ... #Algorithm #Anticoagulation ... #Management #Hematology
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
of Therapy for Venous ... Thrombophilia • Cancer ... Bloodman #VTE #anticoagulation ... #duration #management ... #DVT #hematology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Longterm Venous ... at 3 Months • Cancer ... .2019002364 #Longterm #Venous ... Treatment #Algorithm #management ... #hematology #anticoagulation